Senate Panel Urges FTC to Review Mylan

Lawmakers continued criticizing Mylan over its EpiPen injector, with two leaders of the Senate Judiciary Committee calling for the Federal Trade Commission to review whether Mylan engaged in anti-competitive practices.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news